Details of Protein
General Information of Protein (ID: PRT00628) | |||||
---|---|---|---|---|---|
Name | Excitatory amino acid transporter 2 (SLC1A2) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
Glutamate/aspartate transporter II; Sodium-dependent glutamate/aspartate transporter 2; Solute carrier family 1 member 2; SLC1A2; EAAT2; GLT1
|
||||
Gene Name | SLC1A2 | Gene ID | |||
UniProt ID | |||||
Family | Dicarboxylate/amino acid:cation symporter (DAACS) | ||||
TC Number | TC: 2.A.23.2.7 (Click to Show/Hide the Complete TC Tree) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MASTEGANNMPKQVEVRMHDSHLGSEEPKHRHLGLRLCDKLGKNLLLTLTVFGVILGAVC
GGLLRLASPIHPDVVMLIAFPGDILMRMLKMLILPLIISSLITGLSGLDAKASGRLGTRA MVYYMSTTIIAAVLGVILVLAIHPGNPKLKKQLGPGKKNDEVSSLDAFLDLIRNLFPENL VQACFQQIQTVTKKVLVAPPPDEEANATSAVVSLLNETVTEVPEETKMVIKKGLEFKDGM NVLGLIGFFIAFGIAMGKMGDQAKLMVDFFNILNEIVMKLVIMIMWYSPLGIACLICGKI IAIKDLEVVARQLGMYMVTVIIGLIIHGGIFLPLIYFVVTRKNPFSFFAGIFQAWITALG TASSAGTLPVTFRCLEENLGIDKRVTRFVLPVGATINMDGTALYEAVAAIFIAQMNGVVL DGGQIVTVSLTATLASVGAASIPSAGLVTMLLILTAVGLPTEDISLLVAVDWLLDRMRTS VNVVGDSFGAGIVYHLSKSELDTIDSQHRVHEDIEMTKTQSIYDDMKNHRESNSNQCVYA AHNSVIVDECKVTLAANGKSADCSVEEEPWKREK |
||||
Function | Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate. Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion. Mediates Cl(-) flux that is not coupled to amino acid transport; this avoids the accumulation of negative charges due to aspartate and Na(+) symport. Essential for the rapid removal of released glutamate from the synaptic cleft, and for terminating the postsynaptic action of glutamate. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Organic acids and derivatives | ||||||
DL-Glutamate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of SLC1A2 | |||||
Induced Change | DL-Glutamate concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC1A2 leads to the increase of DL-Glutamate levels compared with control group. | |||||
Glutamic acid | Click to Show/Hide the Full List of Regulating Pair(s): 5 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Overexpression of SLC1A2 | |||||
Induced Change | Glutamic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of SLC1A2 leads to the increase of glutamic acid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Inhibition (Dihydrokainic Acid (DHK)) of SLC1A2 | |||||
Induced Change | Glutamic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that inhibition of SLC1A2 leads to the decrease of glutamic acid levels compared with control group. | |||||
Regulating Pair (3) |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Inhibition (DL-threo-beta-hydroxyaspartic acid (TBHA)) of SLC1A2 | |||||
Induced Change | Glutamic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that inhibition of SLC1A2 leads to the decrease of glutamic acid levels compared with control group. | |||||
Regulating Pair (4) |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Inhibition (Kainic acid (KA)) of SLC1A2 | |||||
Induced Change | Glutamic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that inhibition of SLC1A2 leads to the decrease of glutamic acid levels compared with control group. | |||||
Regulating Pair (5) |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Inhibition (L-trans-pyrrolidine-2,4-dicar-boxylic acid (PDC)) of SLC1A2 | |||||
Induced Change | Glutamic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that inhibition of SLC1A2 leads to the decrease of glutamic acid levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.